Entrada Therapeutics Inc (TRDA)

CapEx to Revenue

1.22%

Quarterly · Period ending:

TRDA logo

TRDA CapEx to Revenue

Latest reported1.22%
TRDA Quarterly CapEx/Revenue (0.00% → 1.22%)
High-resolution chart · PNG

TRDA capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Entrada Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
1.2249%
5.0286%
15.9353%
10.5948%
14.1026%
5.5647%
1.698%
3.2652%
1.1046%
1.4175%
2.3323%
3.3108%
8.3764%
6.6033%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.